Description
What is Colivelin?
Colivelin is a potent synthetic hybrid neuroprotective peptide engineered by fusing the core active sequence of activity-dependent neurotrophic factor (ADNF-9) with a derivative of humanin (AGA-HNG17), creating a dual-mechanism neuroprotectant with broader efficacy than either parent peptide. It was developed by Matsuoka and colleagues as a research tool for studying neuronal survival against multiple neurotoxic insults associated with Alzheimer’s disease. For published research, see PubMed studies on Colivelin{:target=“_blank” rel=“noopener”}.
Colivelin has demonstrated femtomolar-range neuroprotective activity in vitro, making it one of the most potent neuroprotective peptides described in the literature.
Best-Peptides supplies research-grade Colivelin with guaranteed ≥99% purity and full analytical documentation.
How Does Colivelin Work?
STAT3 Pathway Activation
- gp130/IL-27R engagement – Receptor complex activation
- JAK2 phosphorylation – Kinase cascade initiation
- STAT3 dimerisation – Transcription factor activation
- Pro-survival gene induction – Bcl-2 and Bcl-xL upregulation
Dual Neuroprotective Mechanism
- Humanin component – STAT3-mediated neuronal survival
- ADNF component – NF-κB-mediated protection
- Synergistic coverage – Protection against diverse insults
- Femtomolar potency – Ultra-high neuroprotective activity
Anti-Amyloid Protection
- Aβ₁₋₄₂ toxicity rescue – Amyloid-beta-mediated death prevention
- APP mutant protection – V642I-APP neuronal death blockade
- Presenilin rescue – M146L-PS1 toxicity attenuation
- Oxidative stress defence – ROS-mediated damage reduction
Research Applications
Alzheimer’s Disease Modelling
- Amyloid toxicity – Aβ oligomer challenge experiments
- Familial AD mutations – APP and presenilin mutant studies
- Cognitive rescue – In vivo memory impairment models
Neuroprotection Pharmacology
- Potency comparison – Colivelin vs humanin vs ADNF
- Pathway dissection – STAT3 vs NF-κB contribution analysis
- Dose-response profiling – Femtomolar to nanomolar range
Translational Neuroscience
- Blood-brain barrier studies – CNS delivery and penetration
- Biomarker analysis – Neuroprotection readout development
- Combination therapy – Multi-target neuroprotection strategies
Colivelin Specifications
| Specification | Detail |
|---|---|
| CAS Number | 867021-83-8 |
| Molecular Weight | ~3000 Da |
| Structure | ADNF-9 + AGA-HNG17 hybrid |
| Purity | ≥99% (HPLC) |
| Solubility | Soluble in water, PBS |
| Appearance | White lyophilised powder |
Storage and Handling
| Condition | Temperature | Duration |
|---|---|---|
| Lyophilised | -20°C | Up to 24 months |
| Reconstituted | 2-8°C | Up to 4 weeks |
Ordering Information
| Size | Price |
|---|---|
| 10 × 5 mg vials | 400 |
Minimum order: $200 | 10% discount on orders over $200
Research Use Statement
For laboratory research only. Not intended for human or veterinary use. Researchers should follow all applicable regulations.

Hartman –
Your service are extraordinary and I was amazed with how good it was